› $150,000,000 verdict in personal injury case
Two years ago, M.D. Anderson researchers announced a 7 percent drop in breast cancer rates which coincidentally occurred around the same time that women were being told by the media and their doctors of the possible link between hormone replacement therapy (HRT) and serious diseases and conditions such as breast cancer and heart disease.
Women with existing heart conditions should consider their heart disease risk and visit a doctor for a heart health evaluation when considering estrogen hormone replacement therapy (HRT), according to a University of Michigan study.
Nevada’s attorney general is suing drug makers Wyeth and Pfizer for alleged deceptive trade practices and misleading the public about the safety of its hormone replacement therapy (HRT) drugs, according to RGJ.com.
Women who take breast cancer drugs Arimidex or generic tamoxifen and suffer with menopausal symptoms such as hot flashes, night sweats or painful joints may be less likely to have a reoccurrence of their cancer tumors, according to Reuters.
Postmenopausal women who experience a slump in their sex drive may rediscover their libido by taking the male sex hormone testosterone. However, researchers are unsure if there may be a link between the use of testosterone and breast cancer, according to FoodConsumer.org.
Women who have never given birth and women who take postmenopausal hormone replace therapy (HRT) may have a higher risk of severe hip or knee and osteoarthritis, according to a story by Med Page Today. The medical publication credits the Million Women Study, a confidential national study of women’s health involving more than one million UK women aged 50 and older. The project is a collaborative project between Cancer Research UK and the National Health Service and focuses on the effects of HRT. Because the study group is so large, a broad range of topics can be addressed.
Many women begin hearing the silent ticking of their biological clocks when they hit 30. By 40, that ticking can become downright deafening, especially for women who want to have a baby but have yet to conceive. After all, there is no telling when a woman will enter menopause, which would greatly reduce her likelihood of becoming pregnant.
If only there was some way of knowing when our reproductive cycles will end.
Wyeth, the pharmaceutical company that makes hormone replacement therapies Prempro and Premarin, announced today that it is ending its research in its signature areas of contraceptives and menopause treatments to focus on other female problems such as ovarian and breast cancers, according to the Associated Press/Washington Post.
Ovarian cancer is the deadliest of all gynecologic cancers, expected to kill about 15,000 women in 2008, according to the Ovarian Cancer National Alliance. Risk factors remain a mystery; however, researchers believe a woman is at increased risk if she has a family history of cancer, personal history of cancer, is older than 55, has never been pregnant, and has used menopausal hormone therapy.
